Anti-EGFR (phospho Y1173) 抗体 [E124]
Anti-EGFR (phospho Y1173) antibody [E124]
- RabMAb
- Recombinant
- Lab Essentials
- 20ul selling size
- 詳細を見る
Be the first to review this product! Submit a review
|
(38 Publications)
Rabbit Recombinant Monoclonal EGFR phospho Y1173 antibody. Suitable for WB, ICC/IF, Flow Cyt (Intra) and reacts with Human samples. Cited in 38 publications.
別名を表示する
ERBB, ERBB1, HER1, EGFR, Epidermal growth factor receptor, Proto-oncogene c-ErbB-1, Receptor tyrosine-protein kinase erbB-1
- Flow Cyt (Intra)
Unknown
Flow Cytometry (Intracellular) - Anti-EGFR (phospho Y1173) antibody [E124] (AB32578)
Intracellular Flow Cytometry analysis of HeLa (human cervix adenocarcinoma) treated (Red)/untreated (Green) with 500ng/ml Trichostatin A for 4 hours with purified ab177178 at 1/1300 dilution. The secondary antibody was Goat anti rabbit IgG (Alexa Fluorr® 488) at 1/2000 dilution. A Rabbit monoclonal IgG (Black) was used as the isotype control and cells without incubation with primary antibody and secondary antibody (Blue) were used as unlabeled control.
- ICC/IF
Lab
Immunocytochemistry/ Immunofluorescence - Anti-EGFR (phospho Y1173) antibody [E124] (AB32578)
Immunocytochemistry analysis of A431 (Human epidermoid carcinoma epithelial cell) treated with EGF(100ng/ml 5min) cells labeling EGFR with Purified ab32578 at 1 : 2000 dilution (0.1 μg/ml). Cells were fixed in 4% Paraformaldehyde and permeabilized with 0.1% tritonX-100. Cells were counterstained with ab195889 Anti-alpha Tubulin antibody [DM1A] - Microtubule Marker (Alexa Fluor® 594) 1 : 200 (2.5 μg/ml). Goat anti rabbit IgG (Alexa Fluor® 488, ab150077) was used as the secondary antibody at 1 : 1000 (2 μg/ml) dilution. DAPI (blue) was used as nuclear counterstain. PBS instead of the primary antibody was used as the secondary antibody only control.
- WB
Unknown
Western blot - Anti-EGFR (phospho Y1173) antibody [E124] (AB32578)
All lanes:
Western blot - Anti-EGFR (phospho Y1173) antibody [E124] (ab32578) at 1/1000 dilution
Lane 1:
Untreated A431 (Human epidermoid carcinoma epithelial cell) whole cell lysate
Lane 2:
A431 (Human epidermoid carcinoma epithelial cell) treated with 100ng/ml EGF for 30 minutes whole cell lysate
Lane 3:
A431 (Human epidermoid carcinoma epithelial cell) treated with 100ng/ml EGF for 30 minutes whole cell lysate, then the membrane treated with Alkaline Phosphatase for 1 hour
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Predicted band size: 134 kDa
false
- WB
CiteAb
Western blot - Anti-EGFR (phospho Y1173) antibody [E124] (AB32578)
EGFR (phospho Y1173) western blot using anti-EGFR (phospho Y1173) antibody [E124] ab32578. Publication image and figure legend from Bönisch, M., Sellmann, C., et al., 2017, Protein Eng Des Sel, PubMed 28981885.
ab32578 was used in this publication in western blot. This may not be the same as the application(s) guaranteed by Abcam. For a full list of applications guaranteed by Abcam for ab32578 please see the product overview.
Biophysical and functional characterisation of B10v5 × hu225M with or without mutations in the CH1 : CL interface. Analytical SEC after protein A purification of bsAbs produced in (A) HEK293-6E or (B) bsAbs produced in ExpiCHO after preparative SEC. The area under the curve in percent of all detected peak areas is given in the graph. (C) Simultaneous binding of both antigens cMET and EGFR using biolayer interferometry. BsAbs (wt, MaB40, MaB5/40, MaB21/40, MaB45/40) or antibodies consisting of only one Fab (oa for ‘one-armed’) were allowed to bind to cMET coated biosensors. Subsequently, biosensors were incubated with EGFR. (D) Differential scanning calorimetry of wildtype, interface mutants and ‘one-armed’ constructs (Table III). (E) Western blot analysis of the inhibition of EGFR and cMET phosphorylation in A549 cells by bsAbs with our without interface designs.
false
関連する標識済み抗体及び組成の異なる製品 (4)
-
565 Alexa Fluor® 555
Alexa Fluor® 555 Anti-EGFR (phospho Y1173) antibody [E124]
-
665 Alexa Fluor® 647
Alexa Fluor® 647 Anti-EGFR (phospho Y1173) antibody [E124]
-
Anti-EGFR (phospho Y1173) antibody [E124] - BSA and Azide free
-
617 Alexa Fluor® 594
Alexa Fluor® 594 Anti-EGFR (phospho Y1173) antibody [E124]
Reactivity data
製品の詳細
Species reactivity
Mouse, Rat: We have preliminary internal testing data to indicate this antibody may not react with these species.
Please contact us for more information.
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
出荷温度及び保存条件
製品の状態
精製方法
バッファー組成
出荷温度
短期保存期間
短期保存温度
長期保存温度
分注に関する情報
保管に関する情報
補足情報
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
The EGFR protein plays an important role in cellular communication and signaling processes. EGFR pairs with other receptor family members to form active dimers or even higher-order complexes which in turn initiate intracellular signaling cascades. Through these complexes EGFR influences many processes including cell differentiation and repair. This function of EGFR makes it an integral part of mammalian biology affecting how cells respond to their environment by mediating changes in gene expression.
Pathways
EGFR is a central player in the MAPK and PI3K/Akt signaling pathways. Alongside other protein partners like KRAS and PI3 kinase it contributes to transmitting signals from the cell surface to the nucleus affecting gene transcription and cell behavior. These pathways are important for normal cell growth and division and aberrations in these pathways can lead to excessive or insufficient cell proliferation.
製品プロトコール
- Visit the General protocols
- Visit the Troubleshooting
ターゲットの情報
文献 (38)
Recent publications for all applications. Explore the full list and refine your search
Journal of extracellular biology 3:e141 PubMed38939899
2024
Applications
Unspecified application
Species
Unspecified reactive species
Molecular cancer therapeutics 22:667-678 PubMed36921315
2023
Applications
Unspecified application
Species
Unspecified reactive species
Cancer cell 40:754-767.e6 PubMed35820397
2022
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in cardiovascular medicine 9:797137 PubMed35224040
2022
Applications
Unspecified application
Species
Unspecified reactive species
Journal of cellular physiology 237:1780-1789 PubMed34806177
2021
Applications
Unspecified application
Species
Unspecified reactive species
Pathology international 71:752-764 PubMed34528330
2021
Applications
Unspecified application
Species
Unspecified reactive species
Experimental and therapeutic medicine 21:638 PubMed33968169
2021
Applications
Unspecified application
Species
Unspecified reactive species
Carbohydrate polymers 261:117911 PubMed33766385
2021
Applications
Unspecified application
Species
Unspecified reactive species
Neoplasia (New York, N.Y.) 23:36-48 PubMed33217668
2020
Applications
Unspecified application
Species
Unspecified reactive species
International journal of cancer 148:1438-1451 PubMed32949162
2020
Applications
Unspecified application
Species
Unspecified reactive species
Abcam product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com